Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
7.08
+0.02 (0.28%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $259.8 million as of June 18, 2026. Its market cap has increased by 263.45% in one year.
Market Cap
259.80M
Enterprise Value
628.72M
1-Year Change
263.45%
Ranking
Category
Stock Price
$7.08
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $259.80M, an increase of 460.95%. That is a compound annual growth rate of 27.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 259.80M | 13.63% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 263.44M |
| Invivyd | 262.73M |
| SAB Biotherapeutics | 257.21M |
| Zentalis Pharmaceuticals | 250.58M |
| MacroGenics | 246.62M |
| VERAXA Biotech AG | 238.56M |
| Sol-Gel Technologies | 238.21M |
| InflaRx | 235.67M |